Skip to main content
Erschienen in: Breast Cancer Research and Treatment 2/2015

01.06.2015 | Epidemiology

Validation of self-reported post-treatment mammography surveillance among breast cancer survivors by electronic medical record extraction method

verfasst von: Jasmin A. Tiro, Joanne M. Sanders, L. Aubree Shay, Caitlin C. Murphy, Heidi A. Hamann, L. Kay Bartholomew, Lara S. Savas, Sally W. Vernon

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 2/2015

Einloggen, um Zugang zu erhalten

Abstract

Little is known about validity of self-reported mammography surveillance among breast cancer survivors. Most studies have focused on accuracy among healthy, average-risk populations and none have assessed validity by electronic medical record (EMR) extraction method. To assess validity of survivor-reported mammography post-active treatment care, we surveyed all survivors diagnosed 2004–2009 in an academic hospital cancer registry (n = 1441). We used electronic query and manual review to extract EMR data. Concordance, sensitivity, specificity, positive predictive value, and report-to-records ratio were calculated by comparing survivors’ self-reports to data from each extraction method. We also assessed average difference in months between mammography dates by source and correlates of concordance. Agreement between the two EMR extraction methods was high (concordance 0.90; kappa 0.70), with electronic query identifying more mammograms. Sensitivity was excellent (0.99) regardless of extraction method; concordance and positive predictive value were good; however, specificity was poor (manual review 0.20, electronic query 0.31). Report-to-records ratios were both over 1 suggesting over-reporting. We observed slight forward telescoping for survivors reporting mammograms 7–12 months prior to survey date. Higher educational attainment and less time since mammogram receipt were associated with greater concordance. Accuracy of survivors’ self-reported mammograms was generally high with slight forward telescoping among those recalling their mammograms between 7 and 12 months prior to the survey date. Results are encouraging for clinicians and practitioners relying on survivor reports for surveillance care delivery and as a screening tool for inclusion in interventions promoting adherence to surveillance guidelines.
Literatur
2.
Zurück zum Zitat Khatcheressian JL, Hurley P, Bantug E, Esserman LJ, Grunfeld E, Halberg F, Hantel A, Henry NL, Muss HB, Smith TJ, Vogel VG, Wolff AC, Somerfield MR, Davidson NE (2013) Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 31:961–965CrossRefPubMed Khatcheressian JL, Hurley P, Bantug E, Esserman LJ, Grunfeld E, Halberg F, Hantel A, Henry NL, Muss HB, Smith TJ, Vogel VG, Wolff AC, Somerfield MR, Davidson NE (2013) Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 31:961–965CrossRefPubMed
3.
Zurück zum Zitat Khatcheressian JL, Wolff AC, Smith TJ, Grunfeld E, Muss HB, Vogel VG, Halberg F, Somerfield MR, Davidson NE (2006) American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol 24:5091–5097CrossRefPubMed Khatcheressian JL, Wolff AC, Smith TJ, Grunfeld E, Muss HB, Vogel VG, Halberg F, Somerfield MR, Davidson NE (2006) American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol 24:5091–5097CrossRefPubMed
4.
Zurück zum Zitat Bevers TB, Anderson BO, Bonaccio E, Buys S, Daly MB, Dempsey PJ, Farrar WB, Fleming I, Garber JE, Harris RE, Heerdt AS, Helvie M, Huff JG, Khakpour N, Khan SA, Krontiras H, Lyman G, Rafferty E, Shaw S, Smith ML, Tsangaris TN, Williams C, Yankeelov T (2009) NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis. J Natl Compr Cancer Netw 7:1060–1096 Bevers TB, Anderson BO, Bonaccio E, Buys S, Daly MB, Dempsey PJ, Farrar WB, Fleming I, Garber JE, Harris RE, Heerdt AS, Helvie M, Huff JG, Khakpour N, Khan SA, Krontiras H, Lyman G, Rafferty E, Shaw S, Smith ML, Tsangaris TN, Williams C, Yankeelov T (2009) NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis. J Natl Compr Cancer Netw 7:1060–1096
5.
Zurück zum Zitat Smith TJ, Davidson NE, Schapira DV, Grunfeld E, Muss HB, Vogel VG III, Somerfield MR (1999) American Society of Clinical Oncology 1998 update of recommended breast cancer surveillance guidelines. J Clin Oncol 17:1080–1082PubMed Smith TJ, Davidson NE, Schapira DV, Grunfeld E, Muss HB, Vogel VG III, Somerfield MR (1999) American Society of Clinical Oncology 1998 update of recommended breast cancer surveillance guidelines. J Clin Oncol 17:1080–1082PubMed
6.
Zurück zum Zitat Carcaise-Edinboro P, Bradley CJ, Dahman B (2010) Surveillance mammography for Medicaid/Medicare breast cancer patients. J Cancer Surviv 4:59–66CrossRefPubMedCentralPubMed Carcaise-Edinboro P, Bradley CJ, Dahman B (2010) Surveillance mammography for Medicaid/Medicare breast cancer patients. J Cancer Surviv 4:59–66CrossRefPubMedCentralPubMed
7.
Zurück zum Zitat Doubeni CA, Field TS, Ulcickas YM, Rolnick SJ, Quessenberry CP, Fouayzi H, Gurwitz JH, Wei F (2006) Patterns and predictors of mammography utilization among breast cancer survivors. Cancer 106:2482–2488CrossRefPubMed Doubeni CA, Field TS, Ulcickas YM, Rolnick SJ, Quessenberry CP, Fouayzi H, Gurwitz JH, Wei F (2006) Patterns and predictors of mammography utilization among breast cancer survivors. Cancer 106:2482–2488CrossRefPubMed
8.
Zurück zum Zitat Field TS, Doubeni C, Fox MP, Buist DS, Wei F, Geiger AM, Quinn VP, Lash TL, Prout MN, Yood MU, Frost FJ, Silliman RA (2008) Under utilization of surveillance mammography among older breast cancer survivors. J Gen Intern Med 23:158–163CrossRefPubMedCentralPubMed Field TS, Doubeni C, Fox MP, Buist DS, Wei F, Geiger AM, Quinn VP, Lash TL, Prout MN, Yood MU, Frost FJ, Silliman RA (2008) Under utilization of surveillance mammography among older breast cancer survivors. J Gen Intern Med 23:158–163CrossRefPubMedCentralPubMed
9.
Zurück zum Zitat Elston Lafata J, Simpkins J, Schultz L, Chase GA, Johnson CC, Yood MU, Lamerato L, Nathanson D, Cooper G (2005) Routine surveillance care after cancer treatment with curative intent. Med Care 43:592–599CrossRefPubMed Elston Lafata J, Simpkins J, Schultz L, Chase GA, Johnson CC, Yood MU, Lamerato L, Nathanson D, Cooper G (2005) Routine surveillance care after cancer treatment with curative intent. Med Care 43:592–599CrossRefPubMed
10.
Zurück zum Zitat Geller BM, Kerlikowske K, Carney PA, Abraham LA, Yankaskas BC, Taplin SH, Ballard-Barbash R, Dignan MB, Rosenberg R, Urban N, Barlow WE (2003) Mammography surveillance following breast cancer. Breast Cancer Res Treat 81:107–115CrossRefPubMed Geller BM, Kerlikowske K, Carney PA, Abraham LA, Yankaskas BC, Taplin SH, Ballard-Barbash R, Dignan MB, Rosenberg R, Urban N, Barlow WE (2003) Mammography surveillance following breast cancer. Breast Cancer Res Treat 81:107–115CrossRefPubMed
11.
Zurück zum Zitat Breslau ES, Jeffery DD, Davis WW, Moser RP, McNeel TS, Hawley S (2010) Cancer screening practices among racially and ethnically diverse breast cancer survivors: results from the 2001 and 2003 California health interview survey. J Cancer Surviv 4:1–14CrossRefPubMed Breslau ES, Jeffery DD, Davis WW, Moser RP, McNeel TS, Hawley S (2010) Cancer screening practices among racially and ethnically diverse breast cancer survivors: results from the 2001 and 2003 California health interview survey. J Cancer Surviv 4:1–14CrossRefPubMed
12.
Zurück zum Zitat Duffy CM, Clark MA, Allsworth JE (2006) Health maintenance and screening in breast cancer survivors in the United States. Cancer Detect Prev 30:52–57CrossRefPubMed Duffy CM, Clark MA, Allsworth JE (2006) Health maintenance and screening in breast cancer survivors in the United States. Cancer Detect Prev 30:52–57CrossRefPubMed
13.
Zurück zum Zitat Katz ML, Donohue KA, Alfano CM, Day JM, Herndon JE, Paskett ED (2009) Cancer surveillance behaviors and psychosocial factors among long-term survivors of breast cancer. Cancer and Leukemia Group B 79804. Cancer 115:480–488CrossRefPubMedCentralPubMed Katz ML, Donohue KA, Alfano CM, Day JM, Herndon JE, Paskett ED (2009) Cancer surveillance behaviors and psychosocial factors among long-term survivors of breast cancer. Cancer and Leukemia Group B 79804. Cancer 115:480–488CrossRefPubMedCentralPubMed
14.
Zurück zum Zitat Vernon SW, Tiro JA, Meissner HI (2008) Behavioral research in cancer screening. In: Miller SM, Bowen DJ, Croyle RT, Rowland JH (eds) Handbook of cancer control and behavioral science: a resource for researchers, practitioners, and policymakers. American Psychological Association, Washington, DC, pp 255–278 Vernon SW, Tiro JA, Meissner HI (2008) Behavioral research in cancer screening. In: Miller SM, Bowen DJ, Croyle RT, Rowland JH (eds) Handbook of cancer control and behavioral science: a resource for researchers, practitioners, and policymakers. American Psychological Association, Washington, DC, pp 255–278
15.
Zurück zum Zitat Vernon SW, Briss PA, Tiro JA, Warnecke RB (2004) Some methodologic lessons learned from cancer screening research. Cancer 101:1131–1145CrossRefPubMed Vernon SW, Briss PA, Tiro JA, Warnecke RB (2004) Some methodologic lessons learned from cancer screening research. Cancer 101:1131–1145CrossRefPubMed
16.
Zurück zum Zitat Rauscher GH, Johnson TP, Cho YI, Walk JA (2008) Accuracy of self-reported cancer-screening histories: a meta-analysis. Cancer Epidemiol Biomark Prev 17:748–757CrossRef Rauscher GH, Johnson TP, Cho YI, Walk JA (2008) Accuracy of self-reported cancer-screening histories: a meta-analysis. Cancer Epidemiol Biomark Prev 17:748–757CrossRef
17.
Zurück zum Zitat Howard M, Agarwal G, Lytwyn A (2009) Accuracy of self-reports of Pap and mammography screening compared to medical record: a meta-analysis. Cancer Causes Control 20:1–13CrossRefPubMed Howard M, Agarwal G, Lytwyn A (2009) Accuracy of self-reports of Pap and mammography screening compared to medical record: a meta-analysis. Cancer Causes Control 20:1–13CrossRefPubMed
18.
Zurück zum Zitat Norman SA, Localio AR, Zhou L, Bernstein L, Coates RJ, Flagg EW, Marchbanks PA, Malone KE, Weiss LK, Lee NC, Nadel MR (2003) Validation of self-reported screening mammography histories among women with and without breast cancer. Am J Epidemiol 158:264–271CrossRefPubMed Norman SA, Localio AR, Zhou L, Bernstein L, Coates RJ, Flagg EW, Marchbanks PA, Malone KE, Weiss LK, Lee NC, Nadel MR (2003) Validation of self-reported screening mammography histories among women with and without breast cancer. Am J Epidemiol 158:264–271CrossRefPubMed
19.
Zurück zum Zitat Armstrong K, Long JA, Shea JA (2004) Measuring adherence to mammography screening recommendations among low-income women. Prev Med 38:754–760CrossRefPubMed Armstrong K, Long JA, Shea JA (2004) Measuring adherence to mammography screening recommendations among low-income women. Prev Med 38:754–760CrossRefPubMed
20.
Zurück zum Zitat Tang PC, Ralston M, Arrigotti MF, Qureshi L, Graham J (2007) Comparison of methodologies for calculating quality measures based on administrative data versus clinical data from an electronic health record system: implications for performance measures. J Am Med Inform Assoc 14:10–15CrossRefPubMedCentralPubMed Tang PC, Ralston M, Arrigotti MF, Qureshi L, Graham J (2007) Comparison of methodologies for calculating quality measures based on administrative data versus clinical data from an electronic health record system: implications for performance measures. J Am Med Inform Assoc 14:10–15CrossRefPubMedCentralPubMed
22.
Zurück zum Zitat Blumenthal D (2009) Stimulating the adoption of health information technology. N Engl J Med 360:1477–1479CrossRefPubMed Blumenthal D (2009) Stimulating the adoption of health information technology. N Engl J Med 360:1477–1479CrossRefPubMed
23.
Zurück zum Zitat Blumenthal D (2011) Implementation of the federal health information technology initiative. N Engl J Med 365:2426–2431CrossRefPubMed Blumenthal D (2011) Implementation of the federal health information technology initiative. N Engl J Med 365:2426–2431CrossRefPubMed
24.
Zurück zum Zitat Carpentier MY, Tiro JA, Savas LS, Bartholomew LK, Melhado TV, Coan SP, Argenbright KE, Vernon SW (2013) Are cancer registries a viable tool for cancer survivor outreach? A feasibility study. J Cancer Surviv 7:155–163CrossRefPubMedCentralPubMed Carpentier MY, Tiro JA, Savas LS, Bartholomew LK, Melhado TV, Coan SP, Argenbright KE, Vernon SW (2013) Are cancer registries a viable tool for cancer survivor outreach? A feasibility study. J Cancer Surviv 7:155–163CrossRefPubMedCentralPubMed
25.
Zurück zum Zitat Tisnado DM, Adams JL, Liu H, Damberg CL, Chen WP, Hu FA, Carlisle DM, Mangione CM, Kahn KL (2006) What is the concordance between the medical record and patient self-report as data sources for ambulatory care? Med Care 44:132–140CrossRefPubMed Tisnado DM, Adams JL, Liu H, Damberg CL, Chen WP, Hu FA, Carlisle DM, Mangione CM, Kahn KL (2006) What is the concordance between the medical record and patient self-report as data sources for ambulatory care? Med Care 44:132–140CrossRefPubMed
26.
Zurück zum Zitat Zapka JG, Bigelow C, Hurley T, Ford LD, Egelhofer J, Cloud WM, Sachsse E (1996) Mammography use among sociodemographically diverse women: the accuracy of self-report. Am J Public Health 86:1016–1021CrossRefPubMedCentralPubMed Zapka JG, Bigelow C, Hurley T, Ford LD, Egelhofer J, Cloud WM, Sachsse E (1996) Mammography use among sociodemographically diverse women: the accuracy of self-report. Am J Public Health 86:1016–1021CrossRefPubMedCentralPubMed
27.
Zurück zum Zitat Hollowell K, Olmsted CL, Richardson AS, Pittman HK, Bellin L, Tafra L, Verbanac KM (2010) American Society of Clinical Oncology-recommended surveillance and physician specialty among long-term breast cancer survivors. Cancer 116:2090–2098PubMed Hollowell K, Olmsted CL, Richardson AS, Pittman HK, Bellin L, Tafra L, Verbanac KM (2010) American Society of Clinical Oncology-recommended surveillance and physician specialty among long-term breast cancer survivors. Cancer 116:2090–2098PubMed
28.
Zurück zum Zitat Cheung WY, Neville BA, Cameron DB, Cook EF, Earle CC (2009) Comparisons of patient and physician expectations for cancer survivorship care. J Clin Oncol 27:2489–2495CrossRefPubMed Cheung WY, Neville BA, Cameron DB, Cook EF, Earle CC (2009) Comparisons of patient and physician expectations for cancer survivorship care. J Clin Oncol 27:2489–2495CrossRefPubMed
29.
Zurück zum Zitat Johnson TP, O’Rourke DP, Burris JE, Warnecke RB (2005) An investigation of the effects of social desirability on the validity of self-reports of cancer screening behaviors. Med Care 43:565–573CrossRefPubMed Johnson TP, O’Rourke DP, Burris JE, Warnecke RB (2005) An investigation of the effects of social desirability on the validity of self-reports of cancer screening behaviors. Med Care 43:565–573CrossRefPubMed
30.
Zurück zum Zitat Snyder CF, Frick KD, Kantsiper ME, Peairs KS, Herbert RJ, Blackford AL, Wolff AC, Earle CC (2009) Prevention, screening, and surveillance care for breast cancer survivors compared with controls: changes from 1998 to 2002. J Clin Oncol 27:1054–1061CrossRefPubMed Snyder CF, Frick KD, Kantsiper ME, Peairs KS, Herbert RJ, Blackford AL, Wolff AC, Earle CC (2009) Prevention, screening, and surveillance care for breast cancer survivors compared with controls: changes from 1998 to 2002. J Clin Oncol 27:1054–1061CrossRefPubMed
Metadaten
Titel
Validation of self-reported post-treatment mammography surveillance among breast cancer survivors by electronic medical record extraction method
verfasst von
Jasmin A. Tiro
Joanne M. Sanders
L. Aubree Shay
Caitlin C. Murphy
Heidi A. Hamann
L. Kay Bartholomew
Lara S. Savas
Sally W. Vernon
Publikationsdatum
01.06.2015
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 2/2015
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-015-3387-2

Weitere Artikel der Ausgabe 2/2015

Breast Cancer Research and Treatment 2/2015 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.